2024 annual financial data

Compass Therapeutics 2024 Financial results

Compass Therapeutics 2024 financial results with verified reported values.

Direct answer

Revenue was 850,000 USD.

Operating income was -56,625,000 USD and net income was -49,375,000 USD.
Operating cash flow was -44,855,000 USD.

Get free Compass Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
850,000 USD
Operating income
-56,625,000 USD
Net income
-49,375,000 USD
Operating cash flow
-44,855,000 USD